FDA Import Refusal AEK-8530931-6/12/1 — Naxpar Pharma Pvt. Ltd
The FDA refused shipment AEK-8530931-6/12/1 from Naxpar Pharma Pvt. Ltd (India) on May 29, 2025. The refused product falls under Drugs and Biologics — DOMPERIDONE. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- May 29, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61TCY31 DOMPERIDONE
- Charges
- 75